Roche: FDA Grants Breakthrough Device Designation For Bood Test Measuring Lp(a)

(RTTNews) – Swiss drug major Roche Holding AG (RHHBY) announced Wedensday that the Tina-quant lipoprotein Lp(a) RxDx assay has received Breakthrough Device Designation from the U.S. Food and Drug Administration. It is to identify patients who may benefit from innovative Lp(a)-low

admin